Search filters

List of works by Mark Ward

A virtual clinic increases anti-TNF dose intensification success via a treat-to-target approach compared with standard outpatient care in Crohn's disease

scientific article published on 07 May 2020

Editorial: balancing safety and efficacy-6-TGN thresholds in NUDT15 intermediate metabolisers treated with thiopurines

scientific article published on 01 August 2020

Editorial: different tests for different drugs in Crohn's disease, or different tests for different people? Authors' reply.

scientific article published in August 2017

Editorial: infliximab de-escalation in inflammatory bowel disease using a therapeutic drug monitoring strategy-early promise but more data needed

scientific article published on 01 March 2019

Editorial: variability in adalimumab trough and peak serum concentrations - authors' reply.

scientific article

Inadequate storage of subcutaneous biological agents by patients with inflammatory bowel disease: Another factor driving loss of response?

scientific article published in January 2018

Infliximab and adalimumab drug levels in Crohn's disease: contrasting associations with disease activity and influencing factors.

scientific article published on 8 May 2017

Infliximab, adalimumab and vedolizumab concentrations across pregnancy and vedolizumab concentrations in infants following intrauterine exposure

scientific article published on 27 September 2020

Intra-patient variability in adalimumab drug levels within and between cycles in Crohn's disease

scientific article

Review article: consensus statements on therapeutic drug monitoring of anti-tumour necrosis factor therapy in inflammatory bowel diseases.

scientific article

Review article: determination of the therapeutic range for therapeutic drug monitoring of adalimumab and infliximab in patients with inflammatory bowel disease

scientific article published on 21 January 2020

Therapeutic drug monitoring of vedolizumab in inflammatory bowel disease: current data and future directions.

scientific article published on 8 May 2018

Thioguanine in inflammatory bowel disease: Long-term efficacy and safety

scientific article

Thiopurines Dosed to a Therapeutic 6-Thioguanine Level in Combination with Adalimumab Are More Effective Than Subtherapeutic Thiopurine-based Combination Therapy or Adalimumab Monotherapy During Induction and Maintenance in Patients with Long-standi

scientific article published on 3 August 2017

Paulina is supported by:

About Paulina

Help